Michael Kauffman – Biography
Last update: May 26, 2026Executive profile
Michael was Board Member at Zalicus, and Chief Medical Officer at Onyx Pharmaceuticals. Michael Kauffman joined Verastem Oncology in 2025.
Michael Kauffman is currentlyPresident of Development at Verastem Oncology - View - Verastem Oncology org chart
Chairman of the Board at Incendia Therapeutics - View - Incendia Therapeutics org chart
Director at Kyntra Bio - View - Kyntra Bio org chart
Create your alert
to follow the career of Michael Kauffman.
Education
In 1992, Michael Kauffman completed a PhD in Molecular Biology and Biochemistry at Johns Hopkins School of Medicine.
They have also studied at Johns Hopkins School of Medicine :
Find more alumni from Johns Hopkins School of Medicine
More about Michael Kauffman
Selected links
Do you need to know more about Michael Kauffman? More results.
Participate
- Suggest a professional link about Michael Kauffman
- Delete any non-relevant links for Michael Kauffman
Social media
- Michael Kauffman on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Michael Kauffman
The colleagues of Michael Kauffman
Company Colleagues
- At Verastem Oncology, Michael Kauffman has 33 colleagues including Dan Paterson (CEO & President), Paul Bunn (Director)…
- At Incendia Therapeutics, Michael Kauffman has 13 colleagues including Wendye Robbins (CEO), Louis Lange (Director)…
- At Kyntra Bio, Michael Kauffman has 13 colleagues including Thane Wettig (CEO & Director), Jeffrey Edwards (Director)…
Industry Colleagues
- In the Biotechnology industry, Michael Kauffman has 35,918 colleagues in 2,427 companies located in 45 countries. 17,078 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Michael Kauffman.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Michael Kauffman.
